Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
Report Store
UsernamePublicRestriction
Tags:
Consumer OTC Drugs

J&J/Merck "Completes" Sweep Of NAD, Court Ad Challenges

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

Future Tums Ultra ads should not compare the product's acid neutralization capacity with that of Pepcid Complete, the National Advertising Division of the Council of Better Business Bureaus says.

You may also be interested in...



OTC Drug Claim Disputes In Court: P&G’S Lafley Says Take It Outside

Procter & Gamble is working to shift ad claims disputes out of the courts and into resolution processes such as the Council for Better Business Bureaus' National Advertising Division

OTC Drug Claim Disputes In Court: P&G’S Lafley Says Take It Outside

Procter & Gamble is working to shift ad claims disputes out of the courts and into resolution processes such as the Council for Better Business Bureaus' National Advertising Division

OTC Drug Claim Disputes In Court: P&G’S Lafley Says Take It Outside

Procter & Gamble is working to shift ad claims disputes out of the courts and into resolution processes such as the Council for Better Business Bureaus' National Advertising Division

Table

View full table

Related Content

HBW Insight

Topics

Tags:
Consumer OTC Drugs
UsernamePublicRestriction

Register

OM016808

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By